申请人:Biomedica Foscama Industria Chimico-Farmaceutica S.p.A.
公开号:US05114966A1
公开(公告)日:1992-05-19
The herein-described invention concerns new 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofuranes 2-(RS)-substituted, the synthesis procedure and the relative therapeutic use as antioxidizing and radical-scavenging pharmaceuticals with mucoregulation and anti-ischemic properties.
所述发明涉及新的2,3-二氢-5-氧-4,6,7-三甲基苯并呋喃烷2-(RS)-取代物,以及合成程序和相对治疗用途,用作具有粘液调节和抗缺血特性的抗氧化和清除自由基的药物。